首页>Journal of cellular and molecular medicine>4-Aminoethylamino-emodin - a novel potent inhibitor of GSK-3β - acts as an insulin-sensitizer avoiding downstream effects of activated β-catenin
4-Aminoethylamino-emodin - a novel potent inhibitor of GSK-3β - acts as an insulin-sensitizer avoiding downstream effects of activated β-catenin
作者单位：Institute of Biochemistry, Medical Faculty, University of Leipzig, Germany[1]Institute of Molecular Medicine, Faculty of Biology, University of Freiburg, Germany[2]Institute of Biochemistry, Faculty of Biosciences, Pharmacy and Psychology, University of Leipzig[3]Institute of Pharmacy, Faculty of Biosciences, Pharmacy and Psychology, University of Leipzig[4]
换一批
换一批
